Table 2.
Distribution of KIR genes in HPV 16/18 and non 16/18 derived high grade CIN
|
KIRgene |
HPV 16/18 |
Non 16/18 |
p-valuea |
|---|---|---|---|
| n = 30 | n = 29 | ||
|
2DL1 |
28 (93%) |
27 (93%) |
0.97 |
|
2DL2 |
12 (40%) |
16 (55%) |
0.36 |
|
2DL3 |
23 (74%) |
21 (72%) |
0.87 |
|
2DL4 |
30 (100%) |
29 (100%) |
1 |
|
2DL5 |
12 (39%) |
17 (59%) |
0.20 |
|
3DL1 |
29 (96%) |
24 (83%) |
0.10 |
|
3DL2 |
30 (100%) |
29 (100%) |
1 |
|
3DL3 |
30 (100%) |
29 (100%) |
1 |
|
2DS1 |
12 (39%) |
14 (48%) |
0.63 |
|
2DS2 |
15 (48%) |
18 (62%) |
0.42 |
|
2DS3 |
7 (22%) |
6 (21%) |
0.86 |
|
2DS4 |
25 (81%) |
21 (72%) |
0.65 |
|
2DS5 |
12 (39%) |
13 (45%) |
0.83 |
| 3DS1 | 12 (39%) | 13 (45%) | 0.83 |
HPV, Human Papillomavirus; KIR, Killer immunoglobulin-like receptor.
aχ2 test with Yates correction was performed; p-values < 0.05 for significance.